BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9455354)

  • 21. Delineation of target volume for radiotherapy of high-grade gliomas by 99m Tc-MIBI SPECT and MRI fusion.
    Krengli M; Loi G; Sacchetti G; Manfredda I; Gambaro G; Brambilla M; Carriero A; Inglese E
    Strahlenther Onkol; 2007 Dec; 183(12):689-94. PubMed ID: 18040614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. False-negative Tc-99m MIBI scintigraphy in histopathologically proved recurrent high-grade oligodendroglioma.
    Goethals I; De Winter O; Dierckx R; Annovazzi A; Signore A; van de Wiele C
    Clin Nucl Med; 2003 Apr; 28(4):299-301. PubMed ID: 12642708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of post-therapy 99mTc-MIBI single-photon emission computed tomography/computed tomography scan in predicting survival in patients with high-grade glioma.
    Roshdy E; ElNaggar M; Atta H; Kandeel A; Abdel-Wanis M; Abd Elbadee OM; Abdelhafez YG; Mohamed Y
    Nucl Med Commun; 2021 Jun; 42(6):625-632. PubMed ID: 33625186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Differential diagnosis between recurrence of gliomas and radiation necrosis by 201TlCl SPECT].
    Nakamura O; Kosuda S; Okamoto K; Kaneko M; Nakamura H; Shitara N; Suzuki K
    No To Shinkei; 1994 Nov; 46(11):1051-7. PubMed ID: 7873278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison.
    O'Tuama LA; Treves ST; Larar JN; Packard AB; Kwan AJ; Barnes PD; Scott RM; Black PM; Madsen JR; Goumnerova LC
    J Nucl Med; 1993 Jul; 34(7):1045-51. PubMed ID: 8315477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct comparison of thallium-201 and technetium-99m MIBI SPECT of a glioma by receiver operating characteristic analysis.
    Shibata Y; Yamamoto T; Takano S; Katayama W; Takeda T; Matsumura A
    J Clin Neurosci; 2009 Feb; 16(2):264-9. PubMed ID: 19084414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tc-99m MIBI uptake and its relation to the proliferative potential of brain tumors.
    Ak I; Gulbas Z; Altinel F; Vardareli E
    Clin Nucl Med; 2003 Jan; 28(1):29-33. PubMed ID: 12493957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radio-guided brain tumorectomy using a gamma detecting probe and a mobile solid-state gamma camera.
    Kojima T; Kumita S; Yamaguchi F; Mizumura S; Kitamura T; Kumazaki T; Teramoto A
    Surg Neurol; 2004 Mar; 61(3):229-38; discussion 238. PubMed ID: 14984991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of brain tumor by 99mTc-MIBI: comparison study with 201Tl and predictivity of therapeutic effect].
    Nagamachi S; Jinnouchi S; Flores LG; Kodama T; Ohnishi T; Nakahara H; Futami S; Tamura S; Watanabe K; Yokogami K; Kawano H; Wakisaka S
    Kaku Igaku; 1998 Mar; 35(3):121-30. PubMed ID: 9594487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A meta-analysis of 99mTc-MIBI SPECT for detection of recurrent glioma after radiation therapy.
    Cheng X; Li Y; Xu Z; Li D; Wang J
    J Clin Neurosci; 2011 Mar; 18(3):307-12. PubMed ID: 21251837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technetium-99m-MIBI in primary and recurrent head and neck tumors: contribution of bone SPECT image fusion.
    Leitha T; Glaser C; Pruckmayer M; Rasse M; Millesi W; Lang S; Nasel C; Backfrieder W; Kainberger F
    J Nucl Med; 1998 Jul; 39(7):1166-71. PubMed ID: 9669388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of 99mTc-MIBI brain SPECT and proton magnetic resonance spectroscopy (1H-MRS) to assess glioma recurrence after radiotherapy.
    Palumbo B; Lupattelli M; Pelliccioli GP; Chiarini P; Moschini TO; Palumbo I; Siepi D; Buoncristiani P; Nardi M; Giovenali P; Palumbo R
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):88-93. PubMed ID: 16557208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up.
    Samnick S; Bader JB; Hellwig D; Moringlane JR; Alexander C; Romeike BF; Feiden W; Kirsch CM
    J Clin Oncol; 2002 Jan; 20(2):396-404. PubMed ID: 11786566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of the nature of brain tumors using methods of nuclear medicine].
    Ambrus E; Kuncz A; Jánoki G; Vörös E; Szakáll S; Balkay L; Emri M; Trón L; Bodosi M; Csernay L; Pávics L
    Orv Hetil; 1999 Sep; 140(36):1979-83. PubMed ID: 10506821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technetium-MIBI as a glioma imaging agent for the assessment of multi-drug resistance.
    Andrews DW; Das R; Kim S; Zhang J; Curtis M
    Neurosurgery; 1997 Jun; 40(6):1323-32; discussion 1333-4. PubMed ID: 9179912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine.
    Kuwert T; Woesler B; Morgenroth C; Lerch H; Schäfers M; Palkovic S; Matheja P; Brandau W; Wassmann H; Schober O
    J Nucl Med; 1998 Jan; 39(1):23-7. PubMed ID: 9443732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre- and post-therapy thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma.
    Kostakoglu L; Uysal U; Ozyar E; Elahi N; Hayran M; Uzal D; Demirkazik FB; Kars A; Uğur O; Atahan L; Bekdik CF
    J Nucl Med; 1996 Dec; 37(12):1956-62. PubMed ID: 8970513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas.
    Garcia R; Kim EE; Wong FC; Korkmaz M; Wong WH; Yang DJ; Podoloff DA
    J Nucl Med; 1996 Sep; 37(9):1476-9. PubMed ID: 8790197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tc-99m-MIBI and Tc-99m-HMPAO accumulation in primary and metastatic brain tumors assessed by brain SPECT].
    Sygitowicz M; Lass P; Lyczak P; Stepień-Koćmiel E; Taraszewska M; Bandurski T
    Neurol Neurochir Pol; 1998; 32(5):1099-106. PubMed ID: 10463225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study.
    Kurata S; Ushijima K; Kawahara A; Kaida H; Kawano K; Hirose Y; Kage M; Kamura T; Ishibashi M; Abe T
    Ann Nucl Med; 2015 Aug; 29(7):643-9. PubMed ID: 25921216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.